Search

Your search keyword '"Gacic-Dobo, Marta"' showing total 20 results
Start Over Author "Gacic-Dobo, Marta" Journal mmwr. morbidity and mortality weekly report
20 results on '"Gacic-Dobo, Marta"'

1. Progress Toward Measles Elimination — Worldwide, 2000–2022

Author

Minta, Anna A., primary, Ferrari, Matt, additional, Antoni, Sebastien, additional, Portnoy, Allison, additional, Sbarra, Alyssa, additional, Lambert, Brian, additional, Hatcher, Cynthia, additional, Hsu, Christopher H., additional, Ho, Lee Lee, additional, Steulet, Claudia, additional, Gacic-Dobo, Marta, additional, Rota, Paul A., additional, Mulders, Mick N., additional, Bose, Anindya Sekhar, additional, Caro, William Perea, additional, O’Connor, Patrick, additional, and Crowcroft, Natasha S., additional

Published
2023
Full Text
View/download PDF

2. COVID-19 Mortality and Progress Toward Vaccinating Older Adults — World Health Organization, Worldwide, 2020–2022

Author

Wong, Man Kai, primary, Brooks, Donald J., additional, Ikejezie, Juniorcaius, additional, Gacic-Dobo, Marta, additional, Dumolard, Laure, additional, Nedelec, Yoann, additional, Steulet, Claudia, additional, Kassamali, Zyleen, additional, Acma, Ayse, additional, Ajong, Brian N., additional, Adele, Sandra, additional, Allan, Maya, additional, Cohen, Homa Attar, additional, Awofisayo-Okuyelu, Adedoyin, additional, Campbell, Finlay, additional, Cristea, Veronica, additional, De Barros, Stephane, additional, Edward, Ntokwo Vabi, additional, Waeber, Aura R. Escobar Corado, additional, Guinko, Tondri N., additional, Laurenson-Schafer, Henry, additional, Mahran, Mostafa, additional, Carrera, Raquel Medialdea, additional, Mesfin, Samuel, additional, Meyer, Emily, additional, Miglietta, Alessandro, additional, Mirembe, Bernadette B., additional, Mitri, Maribeth, additional, Nezu, Ingrid Hammermeister, additional, Ngai, Stephanie, additional, Ejoh, Ojong Ojong, additional, Parikh, Sydel R., additional, Peron, Emilie, additional, Sklenovská, Nikola, additional, Stoitsova, Savine, additional, Shimizu, Kazuki, additional, Togami, Eri, additional, Jin, Yeo Won, additional, Pavlin, Boris I., additional, Novak, Ryan T., additional, Le Polain, Olivier, additional, Fuller, James A., additional, Mahamud, Abdi Rahman, additional, Lindstrand, Ann, additional, Hersh, Bradley S., additional, O’Brien, Katherine, additional, and Van Kerkhove, Maria D., additional

Published
2023
Full Text
View/download PDF

3. Progress Toward Regional Measles Elimination — Worldwide, 2000–2021

Author

Minta, Anna A., primary, Ferrari, Matt, additional, Antoni, Sebastien, additional, Portnoy, Allison, additional, Sbarra, Alyssa, additional, Lambert, Brian, additional, Hauryski, Sarah, additional, Hatcher, Cynthia, additional, Nedelec, Yoann, additional, Datta, Deblina, additional, Ho, Lee Lee, additional, Steulet, Claudia, additional, Gacic-Dobo, Marta, additional, Rota, Paul A., additional, Mulders, Mick N., additional, Bose, Anindya S., additional, Perea, William A., additional, and O’Connor, Patrick, additional

Published
2022
Full Text
View/download PDF

4. Progress Toward Regional Measles Elimination — Worldwide, 2000–2020

Author

Dixon, Meredith G., primary, Ferrari, Matt, additional, Antoni, Sebastien, additional, Li, Xi, additional, Portnoy, Allison, additional, Lambert, Brian, additional, Hauryski, Sarah, additional, Hatcher, Cynthia, additional, Nedelec, Yoann, additional, Patel, Minal, additional, Alexander, James P., additional, Steulet, Claudia, additional, Gacic-Dobo, Marta, additional, Rota, Paul A., additional, Mulders, Mick N., additional, Bose, Anindya S., additional, Rosewell, Alexander, additional, Kretsinger, Katrina, additional, and Crowcroft, Natasha S., additional

Published
2021
Full Text
View/download PDF

5. Progress Toward Regional Measles Elimination — Worldwide, 2000–2019

Author

Patel, Minal K., primary, Goodson, James L., additional, Alexander, James P., additional, Kretsinger, Katrina, additional, Sodha, Samir V., additional, Steulet, Claudia, additional, Gacic-Dobo, Marta, additional, Rota, Paul A., additional, McFarland, Jeffrey, additional, Menning, Lisa, additional, Mulders, Mick N., additional, and Crowcroft, Natasha S., additional

Published
2020
Full Text
View/download PDF

10. Progress Toward Regional Measles Elimination — Worldwide, 2000–2013

Author

Perry, Robert T., Gacic-Dobo, Marta, Dabbagh, Alya, Mulders, Mick N., Strebel, Peter M., Okwo-Bele, Jean-Marie, Rota, Paul A., and Goodson, James L.

Subjects
Young Adult, Adolescent, Child, Preschool, Incidence, Measles Vaccine, Humans, Infant, Articles, Disease Eradication, Mortality, Child, Global Health, Measles
Abstract

In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan with the objective to eliminate measles in four World Health Organization (WHO) regions by 2015. Member states of all six WHO regions have adopted measles elimination goals. In 2010, the World Health Assembly established three milestones for 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) for children aged 1 year to ≥90% nationally and ≥80% in every district; 2) reduce global annual measles incidence to5 cases per million; and 3) reduce global measles mortality by 95% from the 2000 estimate. This report updates the 2000-2012 report and describes progress toward global control and regional measles elimination during 2000-2013. During this period, annual reported measles incidence declined 72% worldwide, from 146 to 40 per million population, and annual estimated measles deaths declined 75%, from 544,200 to 145,700. Four of six WHO regions have established regional verification commissions (RVCs); in the European (EUR) and Western Pacific regions (WPR), 19 member states successfully documented the absence of endemic measles. Resuming progress toward 2015 milestones and elimination goals will require countries and their partners to raise the visibility of measles elimination, address barriers to measles vaccination, and make substantial and sustained additional investments in strengthening health systems.

Published
2014

11. Global Control and Regional Elimination of Measles, 2000–2012

Author

Perry, Robert T., Gacic-Dobo, Marta, Dabbagh, Alya, Mulders, Mick N., Strebel, Peter M., Okwo-Bele, Jean-Marie, Rota, Paul A., and Goodson, James L.

Subjects
Adolescent, Immunization Programs, Child, Preschool, Measles Vaccine, Humans, Infant, Articles, Disease Eradication, Child, Global Health, Immunization Schedule, Measles
Abstract

In 2010, the World Health Assembly established three milestones toward global measles eradication to be reached by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) for children aged 1 year to ≥90% nationally and ≥80% in every district, 2) reduce and maintain annual measles incidence at5 cases per million, and 3) reduce measles mortality by 95% from the 2000 estimate. After the adoption by member states of the South-East Asia Region (SEAR) of the goal of measles elimination by 2020, elimination goals have been set by member states of all six World Health Organization (WHO) regions, and reaching measles elimination in four WHO regions by 2015 is an objective of the Global Vaccine Action Plan (GVAP). This report updates the previous report for 2000-2011 and describes progress toward global control and regional elimination of measles during 2000-2012. During this period, increases in routine MCV coverage, plus supplementary immunization activities (SIAs) reaching 145 million children in 2012, led to a 77% decrease worldwide in reported measles annual incidence, from 146 to 33 per million population, and a 78% decline in estimated annual measles deaths, from 562,400 to 122,000. Compared with a scenario of no vaccination, an estimated 13.8 million deaths were prevented by measles vaccination during 2000-2012. Achieving the 2015 targets and elimination goals will require countries and their partners to raise the visibility of measles elimination and make substantial and sustained additional investments in strengthening health systems.

Published
2014

14. Progress in Introduction of Pneumococcal Conjugate Vaccine — Worldwide, 2000–2012

Author

Wang, Susan A., Mantel, Carsten F., Gacic-Dobo, Marta, Dumolard, Laure, Cherian, Thomas, Flannery, Brendan, Loo, Jennifer D., Verani, Jennifer R., and Whitney, Cynthia G.

Subjects
Pneumococcal Vaccines, Vaccines, Conjugate, Databases, Factual, Immunization Programs, Child, Preschool, Humans, Infant, Articles, Global Health, World Health Organization, Developing Countries, Immunization Schedule, Pneumococcal Infections
Abstract

Pneumococcal conjugate vaccines (PCVs) are safe and effective for reducing illness and deaths caused by Streptococcus pneumoniae. Recommendations for PCV use from the World Health Organization (WHO) and funding from the GAVI Alliance have resulted in an increase in PCV introductions into national immunization programs, especially in lower-income countries. Additionally, new formulations that cover more serotypes commonly causing disease in lower- and middle-income countries have become available. This report uses WHO data from 2000-2012, stratified by country disease burden characteristics and World Bank country income groups, to describe global progress in PCV introduction. As of December 2012, a total of 86 (44%) WHO member states have added PCV to the routine infant immunization schedule of their national immunization programs; among those, 23 have introduced PCV with GAVI Alliance support. PCV introduction among WHO member states was most common in the Americas Region (60% of member states), followed by the Eastern Mediterranean Region (50%), European Region (49%), African Region (41%), and Western Pacific Region (33%); none of 11 WHO member states in the South-East Asia Region have introduced PCV. Proportions of low- and middle-income countries with PCV introductions were similar. The proportion of the world's birth cohort living in countries with PCV in national immunization programs increased from 1% in 2000 to 31% in 2012. These findings suggest that efforts to increase PCV introduction and use globally are succeeding; however, gaps in PCV use remain in Asia and countries with large birth cohorts, where concerted efforts should be focused.

Published
2013

15. Global Routine Vaccination Coverage, 2015

Author

Casey, Rebecca M., primary, Dumolard, Laure, additional, Danovaro-Holliday, M. Carolina, additional, Gacic-Dobo, Marta, additional, Diallo, Mamadou S., additional, Hampton, Lee M., additional, and Wallace, Aaron S., additional

Published
2016
Full Text
View/download PDF

17. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010–2015

Author

Mulders, Mick N., primary, Rota, Paul A., additional, Icenogle, Joseph P., additional, Brown, Kevin E., additional, Takeda, Makoto, additional, Rey, Gloria J., additional, Ben Mamou, Myriam C., additional, Dosseh, Annick R.G.A., additional, Byabamazima, Charles R., additional, Ahmed, Hinda J., additional, Pattamadilok, Sirima, additional, Zhang, Yan, additional, Gacic-Dobo, Marta, additional, Strebel, Peter M., additional, and Goodson, James L., additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results